dr. agarwala on impact of combining entinostat with pembrolizumab
Published 6 years ago • 174 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:23
dr. agarwala on entinostat for patients with melanoma who progress on pd-1/pd-l1 blockade
-
1:42
dr. agarwala on the significance of os and toxicity results in checkmate-067
-
1:56
dr. agarwala on the role of cytokines in the immunotherapy landscape
-
0:49
combining hdac inhibitors with immunotherapy in melanoma
-
1:57
significance of entinostat/il-2 study in rcc
-
1:22
dr. gupta on phase ib/ii trial of pembrolizumab with bevacizumab in rcc
-
0:34
improving immunotherapy for the treatment of patients with ovarian cancer
-
1:09
clinical implications of neoadjuvant immunotherapy in cscc
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
1:06
advances in car-t cells for hematological malignancies
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer
-
0:52
dr. balar discusses the impact of immunotherapy on bladder cancer
-
1:07
immunotherapy in gynecological cancers
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
1:34
emerald-1: durvalumab, bevacizumab and tace in unresectable hcc
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
3:06
the importance of autologous transplantation in the era of immunotherapy
-
6:12
2020 melanoma agarwala adjuvant therapy of melanoma
-
0:43
dr. seetharamu on immunotherapy treatment for head and neck cancers